banner add

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

from NYT > Health https://ift.tt/pTq5nkA
via IFTTT

No comments

Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’

The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the inte...

Theme images by PLAINVIEW. Powered by Blogger.